Jim Cramer fired a triple buy call Aug. 11 on the "Mad Money" Lightning Round. It came for a stock most people still have not heard of. He backed it up with four words that tell you exactly why.
Let's see where he finds that conviction call. [Buy, buy, buy]. Hinge Health (HNGE) has surged 85.83% year to date, according to Yahoo Finance. That's after hitting a fresh all-time high of $93.13 on Aug. 10.
On top of that, Hinge reported record second-quarter 2026 results on Aug. 4, growing revenue 53% year over year to $213 million, tripling free cash flow to nearly $100 million, and raising full-year guidance. Then it announced a $105 million acquisition to expand into gastrointestinal care. For a company most investors know nothing about, the numbers behind the business are genuinely impressive.
Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg, both of whom had personal experiences with musculoskeletal (MSK) injuries and the frustrating recovery process that followed. The company built an artificial intelligence (AI)-powered platform that delivers automated, personalized MSK care — covering chronic pain, acute injury, and post-surgical rehabilitation — at scale through enterprise employers and health plans. Jim Cramer has terrifying one-word message for tech stock investors Jim Cramer says he's steering clear of one popular stock Jim Cramer reveals 4 surging chip stocks he likes best Jim Cramer's net worth: How much does 'Mad Money's' stock-picking superhost make?
The business model targets the MSK market from the employer side, not the consumer side. Corporations and health plans pay Hinge Health to provide their covered populations with digital physical therapy and care management, reducing downstream medical costs on conditions that are among the most expensive to treat in U.S. health care. As of June 30, 2026, Hinge Health serves 2,929 clients, up 24% year over year, including more than half of the Fortune 100, according to its Q2 earnings release.
The Last Twelve Months (LTM) calculated billings reached $861.8 million, up 52% year over year. The second-quarter financial performance was strong across every metric that matters for a growth company. Revenue of $213 million grew 53% year over year (YoY).
Extract — continue reading at the source.
